Hepatocarcinoma Clinical Trials

7 recruitingLast updated: June 17, 2026

There are 7 actively recruiting hepatocarcinoma clinical trials across 4 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Beijing, China, Bologna, Emilia-Romagna, Italy, Chongqing, China. Updated daily from ClinicalTrials.gov.


Hepatocarcinoma Trials at a Glance

7 actively recruiting trials for hepatocarcinoma are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Beijing, Bologna, and Chongqing. Lead sponsors running hepatocarcinoma studies include Centro di Riferimento Oncologico - Aviano, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Assistance Publique - Hôpitaux de Paris.

Browse hepatocarcinoma trials by phase

About Hepatocarcinoma Clinical Trials

Looking for clinical trials for Hepatocarcinoma? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hepatocarcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hepatocarcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Evaluation of Tissue and Circulating microRNA Profiles in Patients With Hepatocellular Carcinoma Subjected to Thermal Ablation

Hepatocarcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna150 enrolled1 locationNCT07601464
Recruiting

Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches

Hepatocarcinoma
Niguarda Hospital270 enrolled1 locationNCT07432347
Recruiting

Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

Hepatocellular CarcinomaHepatocarcinomaLiver Diseases+1 more
University Hospital Muenster600 enrolled1 locationNCT06523608
Recruiting
Phase 2Phase 3

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Breast CancerOvarian CancerCervical Cancer+7 more
Second Affiliated Hospital of Guangzhou Medical University200 enrolled1 locationNCT03755739
Recruiting

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Hepatocarcinoma
Yue Han828 enrolled17 locationsNCT03356236
Recruiting
Not Applicable

METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors

HepatocarcinomaPancreatic Tumor
Assistance Publique - Hôpitaux de Paris300 enrolled1 locationNCT05794048
Recruiting

A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)

Breast CancerPancreatic CancerGastric Cancer+11 more
Centro di Riferimento Oncologico - Aviano782 enrolled1 locationNCT06028724